Skip to content

TRACON Pharmaceuticals, Inc.

CIK 0001394319

← back to feed
Revenue (TTM)
$9.16M
Q2 Aug 2024
Net Income (TTM)
−$1.53M
+87.7% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$5.92
+92.1% YoY Q2 Aug 2024
Gross Margin
—
Q2 Aug 2024
Operating Margin
-92.7%
Q2 Aug 2024
Net Margin
-16.7%
Q2 Aug 2024
Free Cash Flow (TTM)
−$19.16M
Q2 Aug 2024
Cash
$6.27M
Q2 Aug 2024
Total Debt
$18.85M
Q2 Aug 2024
Shares Outstanding
3.41M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings